Kelly-Gemmell Dorothy Elizabeth bought VKTX
August 1, 2026 · Form 4 insider transaction
Kelly-Gemmell Dorothy Elizabeth bought 40,800 shares of Viking Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 6 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,800
Price
$0.00
Total value
N/A
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateAugust 1, 2026
Filing dateAugust 7, 2026
Shares owned after40,800
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
One-third of the shares subject to the option will vest on each anniversary of the grant date.